Clinical Research Directory

Inclusion Criteria * C-Reactive Protein (hs-CRP) \> 1.0 and ≤ 10 ng/L * BMI ≥ 25 kg/m2 * Aged 20-60 years * Able to provide informed consent and comply with study procedures * Willing to maintain stable body weight and follow his/her habitual diet and physical activity patterns throughout the trial. * Judged by the Investigator to be in general good health on the basis of medical history and screening laboratory tests. * People with no documented disease condition that would interfere with the study endpoints (ie., CVD, diabetes, hypertension, major organ diseases) or taking medication or dietary supplements that may interfere with study endpoints Exclusion Criteria * Current smoker or marijuana user * No history or presence of atherosclerosis/cardiovascular disease, inflammatory disease, diabetes mellitus, or other systemic diseases, psychological or psychiatric disorders that may interfere with study outcomes. * Taking any medications and/or supplements that would interfere with outcomes of the study (i.e., lipid-lowering medications, anti-inflammatory drugs, etc) * Take part in prebiotics, probiotics or drugs active on gastrointestinal motility or a laxative of any class within 1 month * Unstable use of any medication/supplement, this could include marijuana used as -needed for medical reasons * Have a history of cancer, except for non-melanoma skin cancer in past 5 years * Addicted to drugs and/or alcohol (\>4 drinks/day) * Have been exposed to any non-registered drug product within last 30 days. * Working overnight (e.g. 3rd shift of overnight workers) * Excessive exercisers or trained athletes * Have allergies/intolerances to any of the study products. * Extreme dietary habits (ie. vegetarian/vegan) * Excessive coffee/tea drinker (\>4 cups/day) * Actively losing weight/ trying to lose weight (unstable body weight fluctuations of \> 5 kg in 3 months) * Donated blood within last 3 months * Participated in a clinical trial within 1 month * Female who is pregnant, planning to be pregnant, breastfeeding * Any condition the Investigator believes would interfere with his or her ability to provide informed consent or comply with the study protocol, or which might confound